Qingfa Bu

774 total citations · 1 hit paper
13 papers, 535 citations indexed

About

Qingfa Bu is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Qingfa Bu has authored 13 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Qingfa Bu's work include Liver Disease Diagnosis and Treatment (6 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and interferon and immune responses (3 papers). Qingfa Bu is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and interferon and immune responses (3 papers). Qingfa Bu collaborates with scholars based in China and Bangladesh. Qingfa Bu's co-authors include Haoming Zhou, Wantong Su, Lei Li, Ling Lü, Xun Wang, Mingming Wang, Zheng Liu, Qi Wang, Jinren Zhou and Ling Lü and has published in prestigious journals such as Oncogene, Journal of Hepatology and Advanced Science.

In The Last Decade

Qingfa Bu

12 papers receiving 532 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

XBP1 deficiency promotes hepatocyte pyroptosis by impairing mitophagy to activate mtDNA-cGAS-STING signaling in macrophages during acute liver injury

2022 232 citations Zheng Liu, Mingming Wang et al. Redox Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qingfa Bu China	9	277	232	193	77	72	13	535
Wantong Su China	6	336 1.2×	241 1.0×	230 1.2×	87 1.1×	71 1.0×	8	613
Zhongmou Jin United States	9	474 1.7×	167 0.7×	237 1.2×	90 1.2×	29 0.4×	13	778
Keita Saeki Japan	11	250 0.9×	192 0.8×	99 0.5×	47 0.6×	37 0.5×	24	594
Kohei Oda Japan	14	151 0.5×	81 0.3×	240 1.2×	168 2.2×	42 0.6×	46	521
Mrigya Babuta United States	11	251 0.9×	108 0.5×	200 1.0×	56 0.7×	41 0.6×	21	540
Min Lian China	14	134 0.5×	194 0.8×	286 1.5×	189 2.5×	41 0.6×	34	575
Yi Mao China	9	134 0.5×	109 0.5×	231 1.2×	27 0.4×	77 1.1×	19	448
Dapeng Ma China	14	291 1.1×	193 0.8×	86 0.4×	36 0.5×	16 0.2×	22	473
Nina Fallon United States	4	175 0.6×	335 1.4×	168 0.9×	63 0.8×	41 0.6×	5	667
Joo-Yeon Yoo United States	10	216 0.8×	187 0.8×	101 0.5×	69 0.9×	26 0.4×	12	553

Countries citing papers authored by Qingfa Bu

Since Specialization

Citations

This map shows the geographic impact of Qingfa Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfa Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfa Bu more than expected).

Fields of papers citing papers by Qingfa Bu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingfa Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfa Bu. The network helps show where Qingfa Bu may publish in the future.

Co-authorship network of co-authors of Qingfa Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingfa Bu. A scholar is included among the top collaborators of Qingfa Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingfa Bu. Qingfa Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Zhu, Qing, et al.. (2025). Macrophage ATG16L1 promotes liver regeneration after partial hepatectomy. JHEP Reports. 7(5). 101330–101330.

2.

Liang, Yuan, Rui Zhang, Haijun Yu, et al.. (2025). Integrated single-cell and spatial transcriptomic profiling reveals that CD177+ Tregs enhance immunosuppression through apoptosis and resistance to immunotherapy in hepatocellular carcinoma. Oncogene. 44(21). 1578–1591. 2 indexed citations

3.

Liang, Yuan, Qingfa Bu, Wenhua You, et al.. (2024). Single-cell analysis reveals hypoxia-induced immunosuppressive microenvironment in intrahepatic cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(7). 167276–167276. 10 indexed citations

4.

Wang, Qi, Qingfa Bu, Zibo Xu, et al.. (2024). Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy. Clinical and Molecular Hepatology. 30(3). 515–538. 11 indexed citations

5.

Bu, Qingfa, Xiaozhang Xu, Qi Wang, et al.. (2024). ATG16L1 Depletion‐Mediated Activation of the TRAF1 Signaling in Macrophages Aggravates Liver Fibrosis. Mediators of Inflammation. 2024(1). 8831821–8831821. 1 indexed citations

6.

Liu, Zheng, Hao Wang, Leyong Yuan, et al.. (2024). E2F2 Reprograms Macrophage Function By Modulating Material and Energy Metabolism in the Progression of Metabolic Dysfunction‐Associated Steatohepatitis. Advanced Science. 11(48). e2410880–e2410880. 8 indexed citations

7.

Su, Wantong, Rui Zhang, Qi Wang, et al.. (2023). TAK1 deficiency promotes liver injury and tumorigenesis via ferroptosis and macrophage cGAS-STING signalling. JHEP Reports. 5(5). 100695–100695. 61 indexed citations

8.

Liang, Yuan, Siddhartha Biswas, Qingfa Bu, et al.. (2023). Integrated single‐cell transcriptomics reveals the hypoxia‐induced inflammation‐cancer transformation in NASH‐derived hepatocellular carcinoma. Cell Proliferation. 57(4). e13576–e13576. 18 indexed citations

9.

Wang, Qi, Qingfa Bu, Mu Liu, et al.. (2022). XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression. JHEP Reports. 4(11). 100555–100555. 74 indexed citations

10.

Zhou, Haoming, Qingfa Bu, Song Wei, et al.. (2022). Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis. Journal of Hepatology. 77(2). 312–325. 91 indexed citations

11.

Liu, Zheng, Mingming Wang, Xun Wang, et al.. (2022). XBP1 deficiency promotes hepatocyte pyroptosis by impairing mitophagy to activate mtDNA-cGAS-STING signaling in macrophages during acute liver injury. Redox Biology. 52. 102305–102305. 232 indexed citations breakdown →

12.

Zhou, Haoming, Qi Wang, Qingfa Bu, Xun Wang, & Ling Lü. (2022). The role of XBP1 in regulating the progression of non-alcoholic steatohepatitis. Journal of Hepatology. 77. S695–S696. 1 indexed citations

13.

Wang, Qi, Wei Song, Lei Li, et al.. (2021). miR-139-5p sponged by LncRNA NEAT1 regulates liver fibrosis via targeting β-catenin/SOX9/TGF-β1 pathway. Cell Death Discovery. 7(1). 243–243. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact